A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH）

NCT04326348 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytosis

Interventions

DRUG: TQ05105

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.